PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Limewash Media and Design Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

RJW & Partners Extends Global Reach With New Australian Office - Australian office to provide Asia-Pacific base for the firm as it continues to expand its consulting capabilities - RJWPartners.com / LimewashMedia.com
RJW & Partners Extends Global Reach With New Australian Office

 

NewswireToday - /newswire/ - Cambridge, Cambs, United Kingdom, 2009/07/03 - Australian office to provide Asia-Pacific base for the firm as it continues to expand its consulting capabilities - RJWPartners.com / LimewashMedia.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Pricing and market access consultants to the pharmaceutical and medical device industries, RJW & Partners, are delighted to announce the opening of its Asia-Pacific headquarters in Sydney, Australia.

The office, founded to help the company support a growing client need for pricing and market access insights in the region, is headed up by Directors, Guy Bate and Daniel Walsh. Both are experienced pharmaceutical industry consultants with strong networks and in-depth understanding of the healthcare policy environments in the key Asian markets, including China, Japan, Korea and Australia.

Prior to running his own consulting practice in Sydney, Guy was Principal for the Product & Portfolio Strategy practice for IMS Health Consulting in London before relocating to Sydney to head the firm's Australasian practice. During his time at IMS, Guy worked extensively with clients in Asia-Pacific (including Korea, China, Japan, Singapore and Indonesia) to develop IMS's local capabilities and to lead senior client engagements across the region. Before IMS, Guy held positions at Cambridge Pharma Consultancy (now part of IMS Health Consulting), at PA Consulting Group within the Life Sciences & Technology Practice, and as an equities analyst covering the healthcare sector at the investment bank, SG Cowen, in London.

Guy is an Associate Fellow of the Australian Institute of Management. He holds a Wellcome Trust Prize PhD in Molecular Pharmacology and a Bachelor's degree in Physiology.

Daniel worked for several years for Cambridge Pharma Consultancy, advising many of the global top 20 companies on key strategic pricing and market access issues across a broad range of therapeutic areas. Having moved back to Australia Daniel gained further experience as a Senior Consultant with IMS Health's then recent acquisition, the health economics consulting firm M-TAG, developing the strategic pricing and market access capabilities in the Asia-Pacific region. In this role, Daniel led multiple engagements across all of the major countries in the region, developing a strong grasp of the nuances of each country's P&R environment in the process. He left the firm in 2007 to found his own successful consultancy in Sydney.

Daniel holds Bachelor's degrees in Science (biotechnology) and Commerce (Finance).

Guy Bate commented: “Asian markets are rapidly evolving and will drive much of the global pharmaceutical growth in coming years. Strategically they are vital to the success of our client companies. However, as in Western countries, healthcare budgets are under significant strain and pricing and market access for new pharmaceuticals will be a challenge; companies will be competing for a piece of the pie. Therefore, an in-depth understanding of the issues that local payers face, and of the way in which pharmaceutical value should be communicated to address these issues, will be vital. RJW is ideally positioned to help ensure our clients are successful.”

Ad Rietveld, founding Director of RJW & Partners Ltd added: “This is a significant step forward for our business. We are delighted that Guy and Dan have joined the organisation as we have a strong history of working together. This decision was motivated partly by the expectations of our clients, but also by our desire to work with Guy and Dan again – you don’t come across this level of talent in most consultancies and it was an opportunity we had to take advantage of.”

RJW & Partners offer a complete suite of services spanning every stage of the product lifecycle including: pricing and market access strategy development, support planning and audit, global and affiliate strategy implementation, the evaluation of new in or out-licensing opportunities and organisational development and improvement. At the core of each assignment is the wish to make a meaningful and commercially tangible contribution to the development of the client’s business, at whatever stage.

RJW & Partners (rjwpartners.com) was founded in 2008 and is a consultancy with unique capabilities in pricing and market access, focused solely on the pharmaceutical and healthcare sectors. All senior staff have worked at the highest levels in pricing and market access in either government or industry and throughout their consulting careers have personally advised on the pricing and market access strategies for most of today’s leading pharmaceutical brands. The company operates throughout Europe, the US, Canada, Asia-Pacific and Latin America.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Limewash Media and Design Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


RJW & Partners Extends Global Reach With New Australian Office

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Sarah Brereton - LimewashMedia.com 
+44(0)77 9658 3223 sarah[.]limewashmedia.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Limewash Media and Design Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Limewash Media and Design Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)